CSIMarket
 


Elutia Inc   (NASDAQ: ELUT)
Other Ticker:  
 
 

Elutia Inc Accounts Receivables Turnover Ratio from the first quarter 2025 to the first quarter 2023

Quarterly Results, Trends, Rankings, Statistics



 
Elutia Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2025 to a ratio of 8.05, this represents a new company high. This is a clear indication for improving liquidity at Elutia Inc 's clients. Average receivable collection period, for the Elutia Inc in Mar 31 2025 quarter, has decreased to 45 days, compared to 51 days, in the Dec 31 2024 quarter.

If we take a look into Healthcare sector 118 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1131, from overall ranking in the fourth quarter 2024 at 1699.

What is Receivable Turnover Ratio?
What is Elutia Inc Selling?


What is Receivable Turnover Ratio?




ELUT Receivables Turnover Ratio (Mar 31 2025)
I. Quarter
(Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
(Jun 30 2024)
II. Quarter
(Mar 31 2024)
III. Quarter
Y / Y Receivable Change -35.09 % -30.25 % 1.66 % -44.31 % -39.92 %
Y / Y Revenue Change -6.61 % -3.15 % -1.71 % -41.89 % -55.23 %
Receivable Turnover Ratio (TTM) 8.05 7.22 6.78 6.83 6.69
ELUT's Total Ranking # 1131 # 1699 # 1886 # 1474 # 1169
Accounts Receivable average collection period days 45 51 54 53 55
Seq. Receivable Change 25.66 % -22.35 % -16.69 % -20.15 % 35.03 %
Seq. Revenue Change -13.71 % 10.16 % -1 % -0.75 % -10.52 %


Receivable Turnover Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 17
Healthcare Sector # 119
Overall Market # 1131

Receivable Turnover Ratio Statistics
High Average Low
8.05 6.69 3.26
(Mar 31 2025)   (Jun 30 2021)






Financial Statements
Elutia Inc 's Accounts Receivable $ 3 Millions Visit ELUT's Balance sheet
Elutia Inc 's Sales TTM $ 23 Millions Visit ELUT's Income Statement
Sources of ELUT's Revenues Visit ELUT's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ELUT's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ELUT's Growth Rates ELUT's Roa ELUT's Inventory Turnover Ratio ELUT's Dividend Comparisons
ELUT's Profitability Ratios ELUT's Roi ELUT's Asset Turnover Ratio ELUT's Dividend Growth
ELUT's Valuation Ratios ELUT's Roe ELUT's Financial Strength Ratios ELUT's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2025, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Mar 31 2025 Receivable at quarter ending Mar 31 2025
Clene Inc   21.88 $ 0.350  Millions$ 0.016  Millions
Meiragtx Holdings Plc  21.74 $ 34.508  Millions$ 1.587  Millions
Macrogenics Inc   20.68 $ 154.050  Millions$ 7.448  Millions
Precipio inc   20.53 $ 20.029  Millions$ 0.976  Millions
Innovative Eyewear Inc   20.08 $ 1.707  Millions$ 0.085  Millions
Tivic Health Systems Inc   19.29 $ 0.516  Millions$ 0.027  Millions
Xoma Royalty Corporation  19.17 $ 42.909  Millions$ 2.239  Millions
Quipt Home Medical Corp   17.96 $ 586.414  Millions$ 32.657  Millions
Novavax inc   17.94 $ 1,254.962  Millions$ 69.966  Millions
Talkspace Inc   17.56 $ 193.386  Millions$ 11.012  Millions
Milestone Scientific Inc   17.43 $ 8.418  Millions$ 0.483  Millions
Owens and Minor inc   16.53 $ 10,719.639  Millions$ 648.631  Millions
Innovage Holding Corp   16.44 $ 831.684  Millions$ 50.574  Millions
Spero Therapeutics Inc   15.95 $ 44.584  Millions$ 2.796  Millions
Generation Bio Co   15.93 $ 24.556  Millions$ 1.541  Millions
Grail Inc   15.86 $ 157.432  Millions$ 9.925  Millions
Ontrak Inc   15.28 $ 9.890  Millions$ 0.647  Millions
Kiniksa Pharmaceuticals International Plc  15.14 $ 481.166  Millions$ 31.782  Millions
Amneal Pharmaceuticals Inc   14.59 $ 2,868.798  Millions$ 196.580  Millions
Mannkind Corporation  14.48 $ 297.595  Millions$ 20.559  Millions
Icu Medical Inc  14.25 $ 2,419.911  Millions$ 169.876  Millions
China Pharma Holdings Inc  13.28 $ 4.295  Millions$ 0.323  Millions
Rosecliff Acquisition Corp I  13.04 $ 29.581  Millions$ 2.268  Millions
Day One Biopharmaceuticals Inc   13.02 $ 161.922  Millions$ 12.440  Millions
Voyager Therapeutics Inc   12.89 $ 66.958  Millions$ 5.196  Millions
Pluri Inc  12.69 $ 1.009  Millions$ 0.080  Millions
National Research Corporation  12.64 $ 141.298  Millions$ 11.177  Millions
Sangamo Therapeutics Inc   12.57 $ 63.756  Millions$ 5.071  Millions
Longeveron Inc   12.52 $ 2.225  Millions$ 0.178  Millions
Dyadic International Inc  12.07 $ 3.554  Millions$ 0.294  Millions

Date modified: 2025-05-15T07:40:47+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com